Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

News Trending Portfolio

TOOLS

Top Insiders Stocks

Top Smart Score Stocks

STOCKS

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Best Biotech Stocks

Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).

Compare up to 10 stocks

GILD AMGN VRTX BIIB ILMN REGN MRNA IQV BNTX

Comparison Results

Name	Price	Price Change	Volume	Market Cap	Analyst Price Target	Analyst Consensus	Smart Score	Article	Follow
GILD Gilead Sciences	$77.01	$0.5 (0.65%)	7.45M	$95.32B	xxxxxxxxxxxxx	11 Buy 10 Hold 0 Sell Moderate Buy
AMGN Amgen	$334.85	$0.55 (0.16%)	1.52M	$179.33B	xxxxxxxxxxxxx	12 Buy 8 Hold 1 Sell Moderate Buy
VRTX Vertex Pharmaceuticals	$495.26	$3 (0.61%)	774.13K	$127.03B	xxxxxxxxxxxxx	17 Buy 5 Hold 2 Sell Moderate Buy
BIIB Biogen	$211.17	$16.27 (7.15%)	2.26M	$33.11B	xxxxxxxxxxxxx	16 Buy 3 Hold 0 Sell Strong Buy
ILMN Illumina	$120.43	$3.13 (2.67%)	1.47M	$18.69B	xxxxxxxxxxxxx	10 Buy 8 Hold 3 Sell Moderate Buy
REGN Regeneron	$1078.63	$14.44 (1.36%)	380.90K	$117.24B	xxxxxxxxxxxxx	19 Buy 1 Hold 0 Sell Strong Buy
MRNA Moderna	$122.11	$1.71 (1.42%)	1.89M	$46.14B	xxxxxxxxxxxxx	9 Buy 7 Hold 2 Sell Moderate Buy
IQV IQVIA Holdings	$239.67	$7.38 (3.18%)	1.20M	$42.35B	xxxxxxxxxxxxx	13 Buy 2 Hold 0 Sell Strong Buy
BNTX BioNTech SE	$85.94	$1.26 (1.49%)	265.28K	$20.13B	xxxxxxxxxxxxx	5 Buy 7 Hold 1 Sell Moderate Buy

Performance Comparison

GILD

Gilead Sciences

76.51

3.09

4.21%

AMGN

Amgen

334.30

105.40

46.05%

VRTX

Vertex Pharmaceuticals

492.26

142.62

40.79%

BIIB

Biogen

227.44

-35.35

-13.45%

ILMN

Illumina

117.30

-67.06

-36.37%

REGN

Regeneron

1,064.19

319.53

42.91%

MRNA

Moderna

120.40

1.89

1.59%

IQV

IQVIA Holdings

232.29

7.73

3.44%

BNTX

BioNTech SE

84.68

-20.32

-19.35%

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Biotech Stocks Latest News

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

TOKYO and CAMBRIDGE, Mass., July 26, 2024 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO:...

17h ago

Gilead Science Stock (NASDAQ:GILD): The Path to a $105 Price Target

Gilead Science Stock (NASDAQ:GILD): The Path to a $105 Price Target

Biopharmaceutical company Gilead Sciences ($GILD) has recently garnered significant attention from Wall Street, with analysts setting ambitious price...

1d ago

Unusually active option classes on open July 25th

Unusually active option classes on open July 25th

Unusual total active option classes on open include: Paycom (PAYC), Stellantis NV (STLA), Warner Bros. Discovery (WBD), iShares...

2d ago

QQQ ETF Update, 7/25/2024

QQQ ETF Update, 7/25/2024 

How is QQQ stock faring? The Invesco QQQ ETF is down 3.47% in the past 5 days but has risen...

2d ago

Gilead call volume above normal and directionally bullish

Gilead call volume above normal and directionally bullish

Bullish option flow detected in Gilead with 6,718 calls trading, 3x expected, and implied vol increasing over 6...

3d ago

Sage Therapeutics, Biogen report results from Phase 2 study of SAGE-324

Sage Therapeutics, Biogen report results from Phase 2 study of SAGE-324

Sage Therapeutics (SAGE) and Biogen (BIIB) announced topline results from the Phase 2 KINETIC 2 dose-range study of...

3d ago

Gilead announces results from PURPOSE 1 trial

Gilead announces results from PURPOSE 1 trial

Gilead announced full efficacy and safety results from its pivotal, Phase 3 PURPOSE 1 trial. Detailed data from...

3d ago

Iqvia downgraded to Hold from Buy at Jefferies

Iqvia downgraded to Hold from Buy at Jefferies

Jefferies downgraded Iqvia (IQV) to Hold from Buy with a price target of $242, down from $266. Biotech...

3d ago

Moderna appoints David Rubenstein to board of directors

Moderna appoints David Rubenstein to board of directors

Moderna (MRNA) announced that David Rubenstein, Co-Founder and Co-Chairman of The Carlyle Group (CG), will join Moderna’s Board...

4d ago

Iqvia price target raised to $300 from $292 at Truist

Iqvia price target raised to $300 from $292 at Truist

Truist analyst Jailendra Singh raised the firm’s price target on Iqvia to $300 from $292 and keeps a...

4d ago

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Biotech Stocks

Biogen

Buy

Reiterated

2024-07-26

Regeneron

Buy

Assigned

2024-07-26

Gilead Sciences

Hold

Assigned

2024-07-25

IQVIA Holdings

Hold

Reiterated

2024-07-24

Amgen

Buy

Reiterated

2024-07-23

Vertex Pharmaceuticals

Buy

Reiterated

2024-07-23

BioNTech SE

Hold

Reiterated

2024-07-22

Moderna

Buy

Reiterated

2024-07-18

Illumina

Buy

Upgraded

2024-07-10

Biogen

Buy

Reiterated

2024-07-26

Most Recent Earnings of Biotech Stocks

Gilead Sciences

Apr 25, 2024

Mar 01, 2024

-1.49 / -1.32

1.34

Amgen

May 02, 2024

Mar 01, 2024

3.88 / 3.96

5

Vertex Pharmaceuticals

May 06, 2024

Mar 01, 2024

4.07 / 4.76

3.89

Biogen

Apr 24, 2024

Mar 01, 2024

3.47 / 3.67

4.02

Illumina

May 02, 2024

Mar 01, 2024

0.04 / 0.09

0.311

Regeneron

May 02, 2024

Mar 01, 2024

10.17 / 9.55

10.24

Moderna

May 02, 2024

Mar 01, 2024

-3.56 / -3.07

-3.62

IQVIA Holdings

Jul 22, 2024

Jun 01, 2024

2.56 / 2.64

2.49

BioNTech SE

May 06, 2024

Mar 01, 2024

-1.35 / -1.42

-0.79

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

Biogen - Strong Buy, based on 19 analyst ratings, 16 Buy, 3 Hold, and 0 Sell.

Regeneron - Strong Buy, based on 20 analyst ratings, 19 Buy, 1 Hold, and 0 Sell.

IQVIA Holdings - Strong Buy, based on 15 analyst ratings, 13 Buy, 2 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $77.01, and its average 12-month price target is $81.26.

Amgen's stock price is currently $334.85, and its average 12-month price target is $323.18.

Vertex Pharmaceuticals's stock price is currently $495.26, and its average 12-month price target is $479.65.

Biogen's stock price is currently $211.17, and its average 12-month price target is $279.88.

Illumina's stock price is currently $120.43, and its average 12-month price target is $142.90.

Regeneron's stock price is currently $1,078.63, and its average 12-month price target is $1,150.06.

Moderna's stock price is currently $122.11, and its average 12-month price target is $144.71.

IQVIA Holdings's stock price is currently $239.67, and its average 12-month price target is $277.14.

BioNTech SE's stock price is currently $85.94, and its average 12-month price target is $112.45.

Which Biotech stocks pay dividends?

Gilead Sciences does not currently pay dividends.

Amgen does not currently pay dividends.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.